Coherus Biosciences Inc drugs

2 results

  • cimerli - ranibizumab - eqrn injection, solution

    (Ranibizumab-Eqrn)
    Coherus Biosciences Inc
    Cimerli treats neovascular (wet) age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema, diabetic retinopathy, and myopic choroidal neovascularization.
    Medication Details
    Drug Interactions

  • yusimry - adalimumab - aqvh injection, solution

    (Adalimumab-Aqvh)
    Coherus Biosciences Inc
    YUSIMRY is a TNF blocker indicated for rheumatoid arthritis, juvenile idiopathic arthritis (age 2+), psoriatic arthritis, ankylosing spondylitis, Crohn's disease (age 6+), ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults.
    Medication Details
    Drug Interactions